NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.
Read Original Story

Study adds evidence that bone drugs work, are safe

Rating

5 Star

Study adds evidence that bone drugs work, are safe

Our Review Summary

Although these drugs are supposed to strengthen bone, some reports have raised the possibility that they actually may increase the likelihood of an unusual type of fracture for some women. For the most part, this story provides a thorough look at new research suggesting that these fractures are extremely rare and do not offset the drugs’ benefits. The story would have been better had it included some discussion of the other potentially serious harms associated with the use of these drugs.      

 

Why This Matters

Hip fractures are a common and often devastating result of osteoporosis. While bisphosphonates are proven to help prevent osteoporotic fractures, recent reports have raised concern about whether a rare type of thigh fracture might be more common in women taking these drugs.
Women need to know whether bisphosphonate drugs work as advertised, and whether the harms outweigh the benefits.   

Criteria

Does the story adequately discuss the costs of the intervention?

Satisfactory

Treatment costs for both Fosamax and Reclast are provided.

Does the story adequately quantify the benefits of the treatment/test/product/procedure?

Satisfactory

The story characterizes the benefits of these drugs in a way that is accurate and easy for readers to understand. It notes that treating 1,000 osteoporotic women for three years would prevent 100 fractures at a possible cost of only one or fewer thigh bone fractures. 

Does the story adequately explain/quantify the harms of the intervention?

Not Satisfactory

The major thrust of the story was the discussion of increased fracture risk associated with use of some bisphosphonates. While the story did an excellent job of discussing the evidence for this particular harm, it didn’t mention any of the other adverse effects  that have been associated with the use of these drugs. These range from common but minor problems such as gastrointestinal upset to rare but potentially serious conditions such as chronic severe muscle pain and kidney damage.  

Does the story seem to grasp the quality of the evidence?

Satisfactory

The story provides enough detail for readers to make reasonable judgments about the quality of the evidence. It notes that the study included data from three controlled trials involving more than 14,000 women. It also discusses some limitations in the data, including the fact that many users hadn’t taken the drugs for very long or used a lower dose of the drug than is commonly used today. The story gives the appropriate impression that the study was strong but that it can’t definitively rule out increased risk of these fractures in bisphosphonate users. 

Does the story commit disease-mongering?

Satisfactory

No disease-mongering in this story.

Does the story use independent sources and identify conflicts of interest?

Satisfactory

The story quotes from an editorial by a researcher not affiliated with the study. It also does an excellent job of discussing the various financial conflicts that might complicate interpretation of the results. It notes that several authors of the study consult for the drugmakers who sponsored the research. It also notes that the editorial writer’s institution received research grants from drugmakers, even though she herself did not have any financial ties to these companies.   

Does the story compare the new approach with existing alternatives?

Satisfactory

The story could have discussed the role of calcium, vitamin D, and weight-bearing exercise for preventing osteoporosis-related fractures. However, we thought it was acceptable for the article to focus exclusively on bisphosphonates, since its point was to discuss risks associated with these agents.

Does the story establish the availability of the treatment/test/product/procedure?

Satisfactory

The story states that the drugs are taken by millions of American women, so readers can assume that they are widely available.

Does the story establish the true novelty of the approach?

Satisfactory

The story makes it clear that these drugs have been in use for some time and should not be considered "new."

Does the story appear to rely solely or largely on a news release?

Satisfactory

It’s clear the story didn’t rely on a news release.

Total Score: 9 of 10 Satisfactory

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.